Global Coalition for Adaptive Research

Global Coalition for Adaptive Research (GCAR) is a groundbreaking initiative dedicated to accelerating the discovery and development of treatments for patients grappling with rare and deadly diseases. Founded in 2017 and headquartered in the United States, GCAR serves as the catalyst for collaboration among physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma entities, health authorities, and other key stakeholders in healthcare. By spearheading innovative trials, including master protocols and adaptive platform trials, GCAR is revolutionizing the clinical trial landscape to support more efficient and cost-effective drug development. This pioneering approach is aimed at modernizing clinical trials, ultimately resulting in superior treatments and more lives saved. With its focus on adaptive platform trials, GCAR has successfully reduced the timeline from lab discovery to clinical implementation, providing unmatched speed and agility in the quest for better treatments.